{
  "actions": [
    {
      "acted_at": "2022-05-26",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2022-05-26",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s4338-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "P000603",
      "district": null,
      "name": "Paul, Rand",
      "original_cosponsor": true,
      "sponsored_at": "2022-05-26",
      "state": "KY",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-05-26",
  "number": "4338",
  "official_title": "A bill to provide for increased transparency in generic drug applications.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr7032-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "hr7667-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Increasing Transparency in Generic Drug Applications Act",
  "sponsor": {
    "bioguide_id": "H001076",
    "district": null,
    "name": "Hassan, Margaret Wood",
    "state": "NH",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-05-26",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Health",
    "Prescription drugs"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2022-05-26",
    "date": "2022-10-18T14:59:09Z",
    "text": "Increasing Transparency in Generic Drug Applications Act\n\nThis bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why)."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increasing Transparency in Generic Drug Applications Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Increasing Transparency in Generic Drug Applications Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to provide for increased transparency in generic drug applications.",
      "type": "official"
    }
  ],
  "updated_at": "2023-10-11T19:30:36Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s4338.xml"
}